Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3431 | ALEC Alector, Inc. - Common Stock | 2.36 USD | 0.00% | +15.12% | +60.54% | -6.72% | 263.51 M USD | ||
| 3446 | WHWK Whitehawk Therapeutics, Inc. - Common Stock | 4.87 USD | +2.96% | +5.18% | +29.52% | +61.79% | 277.63 M USD | ||
| 3454 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.20 USD | -0.31% | +7.38% | -1.54% | -35.74% | 253.20 M USD | ||
| 3455 | MGNX MacroGenics, Inc. - Common Stock | 4.03 USD | -1.71% | -3.59% | +8.92% | +132.95% | 256.71 M USD | ||
| 3465 | PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.42 USD | +3.42% | +26.04% | +35.96% | +6.61% | 254.97 M USD | ||
| 3492 | PYXS Pyxis Oncology, Inc. - Common Stock | 2.98 USD | -3.25% | -1.32% | +12.88% | +120.74% | 248.56 M USD | ||
| 3498 | CGEN Compugen Ltd. - Ordinary Shares | 2.58 USD | -1.53% | +9.79% | +10.26% | +77.93% | 243.95 M USD | ||
| 3500 | GLSI Greenwich LifeSciences, Inc. - Common stock | 16.68 USD | +0.06% | -2.06% | +23.19% | +44.92% | 244.83 M USD | ||
| 3503 | SION Sionna Therapeutics, Inc. - Common Stock | 5.36 USD | +1.32% | -11.26% | -88.36% | -86.38% | 242.34 M USD | ||
| 3519 | DTIL Precision BioSciences, Inc. - Common Stock | 8.50 USD | -3.95% | +15.02% | +16.60% | +69.32% | 234.61 M USD | ||
| 3539 | CLLS Cellectis S.A. - American Depositary Shares | 3.20 USD | -6.16% | +2.89% | +11.50% | +15.52% | 229.60 M USD | ||
| 3542 | NERV Minerva Neurosciences, Inc - Common Stock | 4.88 USD | +0.83% | +8.44% | +19.32% | +99.18% | 233.01 M USD | ||
| 3558 | IMUX Immunic, Inc. - Common Stock | 16.70 USD | +1.21% | +1.95% | +25.00% | +1657.89% | 227.86 M USD | ||
| 3561 | TARA Protara Therapeutics, Inc. - Common Stock | 3.84 USD | -0.26% | -3.76% | -5.65% | +22.68% | 226.93 M USD | ||
| 3563 | RNA Atrium Therapeutics, Inc. - Common Stock | 13.44 USD | +1.82% | +4.75% | +15.76% | -80.89% | 229.90 M USD | ||
| 3566 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 3.10 USD | -1.90% | +16.54% | +41.55% | +103.95% | 224.18 M USD | ||
| 3570 | CHRS Coherus Oncology, Inc. - Common Stock | 1.39 USD | -2.11% | +18.80% | -4.79% | -13.66% | 214.76 M USD | ||
| 3572 | PEPG PepGen Inc. - Common Stock | 3.18 USD | +1.27% | +6.35% | +63.08% | +140.91% | 220.25 M USD | ||
| 3573 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.36 USD | -0.23% | +10.38% | +11.79% | -38.59% | 220.42 M USD | ||
| 3581 | NBP NovaBridge Biosciences - American Depositary Shares | 1.87 USD | -6.50% | -3.61% | +5.65% | -58.54% | 215.76 M USD |
Notizie Biotechnology Stocks
Il titolo azionario di Alto Neuroscience raggiunge il massimo storico a 35,42 USD
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.06 | +635.71% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.78 | +21.88% |
GOSS Gossamer Bio, Inc. - Common Stock | 0.18 | +20.00% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.59 | +16.06% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.76 | +13.55% |
NTRB Nutriband Inc. - Common Stock | 5.29 | +13.28% |
CRDF Cardiff Oncology, Inc. - Common Stock | 0.98 | +11.36% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0041 | -54.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.21 | -23.41% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.89 | -21.26% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.31 | -14.63% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.50 | -14.00% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |